Don’t miss your chance to hear top experts speak at the “Ask the Experts” session at OCRFA’s Ovarian Cancer National Conference. Ask the Experts panelists include: We’ve extended our Ask the Experts Q&A session, giving you more time to learn and more time to answer your questions about ovarian cancer research, science and clinical trials. … Continued
(May 18, 2018) Just last month, three of OCRFA’s research advocates attended the 5 day AACR meeting in Chicago, Illinois to learn about new therapies and innovative technology, stay up to date on current projects, and attend lectures from ovarian cancer researchers such as Dr. Anil Sood of MD Anderson and Dr. Dineo Khabele of … Continued
Donate Now It was August of 2001 when I awoke one evening with a stabbing pain in my side that was so serious, I headed straight to the emergency room. I left with a diagnosis of “depression” and a bottle of painkillers. Something inside me – a gut feeling I can’t explain – told me … Continued
(May 4, 2018) JAMA Oncology recently published a study that looked at the risk of breast cancer in BRCA1 carriers who underwent a prophylactic bilateral salpingo-oophorectomy, a surgery that removes both ovaries before any sign of disease, followed by hormone replacement therapy (HRT). Eight hundred and seventy two women were followed for around 7.5 years … Continued
(April 27, 2018) An OCRFA supported study, recently published in Oncogene, delved into the mechanics of how ovarian cancer spreads throughout the body. Researchers at Johns Hopkins, including OCRFA grantee and lead author Ie-Ming Shih, MD, PhD, investigated spleen tyrosine kinase (SYK), which is heavily involved in ovarian cancer tumor progression, in an effort to … Continued
(April 26, 2018) The International Journal of Gynecological Cancer recently featured a retrospective study on the treatment patterns of women with advanced high-grade serous ovarian carcinoma (HGSC). Of the 852 women with HGSC included in the study, 53% of them underwent primary cytoreductive surgery (PCS), or surgery before chemotherapy to remove as much of the tumor … Continued
(April 24, 2018) Science Advances recently published a study that succeeded in detecting HE4, a biomarker for high-grade serous ovarian cancer (HGSC), by implanting an optical sensor near a disease site in mice. HE4, like CA-125, is approved by the U.S. Food and Drug Administration as a biomarker for HGSC. However, these biomarkers are more … Continued
Join ovarian cancer survivors, caregivers, researchers and healthcare providers at OCRFA’s Ovarian Cancer National Conference – an informative and transformative weekend of hope, inspiration and fun. Get a front row seat at expert plenary and breakout sessions, from the newly-expanded Ask the Experts, to sessions on understanding PARP inhibitors, and sexual health after cancer. Learn … Continued
(April 17, 2018) Science Translational Medicine recently published a University of Pennsylvania Perelman School of Medicine/University of Lausanne, Switzerland study on using a patient’s immune system to fight their cancer. In this pilot trial, 25 patients with advanced epithelial recurrent ovarian cancer were either given the vaccine alone, with the chemotherapy drug bevacizumab, or a … Continued
A tantalizing menu of irresistible treats, crafted by the region’s top female chefs, mixologists and restaurateurs, awaits you at Boston College Club on May 8th. Indulge to your heart’s delight, and be sure to save room for rich chocolate buttermilk cake with dark chocolate ganache, courtesy of Pastry Chef Mareena McKenzie of Strip-T’s. Mareena was … Continued
(April 10, 2018) Patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who have had at least a partial response to platinum based chemotherapy have a new, FDA approved option for maintenance therapy. The evidence that led to the FDA approving rucaparib comes from the phase 3 ARIEL3 clinical trial, which enrolled 564 … Continued
(April 4, 2018) It’s an exciting time for ovarian cancer research! Ovarian cancer clinicians, researchers and advocates came together in New Orleans at the end of March for the Annual Meeting on Women’s Cancer, hosted by the Society of Gynecologic Oncology (SGO). Meeting attendees learned about the latest developments in ovarian cancer research, treatment, and … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
